Alaunos Therapeutics | ZIOP - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Alaunos Therapeutics USD 864K 269K 2026-06
Amgen USD 23.23B 2.27B 2026-09
AstraZeneca USD 31.27B 286M 2026-09
Baxter International USD 3.81B 218M 2026-09
Biogen USD 3.9B 18.7M 2026-09
Bioline Rx USD 13.68M 55K 2026-06
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Celltrion KRW 288.01B 4.7B 2026-06
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Curis USD 14.97M 898K 2026-03
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 28.51M 5.87M 2026-09
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 55.46B 562M 2026-09
Kangmei Pharma CNY 5.1B 280.48M 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Merck USD 28.8B 1.07B 2026-09
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Novartis USD 32.52B 777M 2026-09
Organigram Holdings CAD 107.28M 18.54M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 31.73B 920M 2026-09
Pharma Mar EUR 125.39M 26.97M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Qiagen NV USD 581.45M 102.34M 2026-06
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sartorius EUR 1.55B 102.8M 2026-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
TG Therapeutics USD 268.49M 81.38M 2026-06
Tilray USD 259.32M 8.32M 2025-09
Verastem USD 66.84M 5.42M 2026-03
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.74B 277.02M 2026-09